Search

Displaying results 2441 - 2450 of 2453 in total
  1. Drug

    Flibanserin

    go.drugbank.com/drugs/DB04908
    ApprovedInvestigational

    Flibanserin is the first drug to be approved for hypoactive sexual desire disorder (HSDD) in premenopausal women by the FDA in August 2015. In February of 2018 Flibanserin was approved by Health Canada under the brand name Addyi for a si...

    Categories: Cytochrome P-450 Substrates, P-glycoprotein inhibitors
  2. Drug

    Clevidipine

    go.drugbank.com/drugs/DB04920
    ApprovedInvestigational

    Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers
  3. Drug

    Indacaterol

    go.drugbank.com/drugs/DB05039
    ApprovedInvestigational

    Indacaterol is a novel, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (...

    Categories: P-glycoprotein substrates, Cytochrome P-450 Substrates
  4. Drug

    Telmapitant

    go.drugbank.com/drugs/DB20768
    Experimental

    The usage of the INN stem '-pitant' in the name indicates that Telmapitant is a neurokinin NK1​ (substance P) receptor antagonist. Telmapitant has a monoisotopic molecular weight of 515.16 Da.

  5. Drug

    Taltobulin

    go.drugbank.com/drugs/DB20832
    Experimental

    Taltobulin is a small molecule drug. Taltobulin has a monoisotopic molecular weight of 473.33 Da.

    Categories: P-glycoprotein substrates
  6. Drug

    Tabimorelin

    go.drugbank.com/drugs/DB20892
    Experimental

    Tabimorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Tabimorelin is a pituitary hormone-release stimulating peptide. Tabimorelin has a monoisotopic molecular weight of 528.31 Da.

    Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors
  7. Drug

    Dapitant

    go.drugbank.com/drugs/DB20991
    Experimental

    The usage of the INN stem '-pitant' in the name indicates that Dapitant is a neurokinin NK1​ (substance P) receptor antagonist. Dapitant has a monoisotopic molecular weight of 561.29 Da.

  8. Drug

    Lapisteride

    go.drugbank.com/drugs/DB21206
    Experimental

    Lapisteride is a small molecule drug. The usage of the INN stem '-steride' in the name indicates that Lapisteride is a androgen/anabolic steroid. Lapisteride has a monoisotopic molecular weight of 464.3 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  9. Drug

    Metacetamol

    go.drugbank.com/drugs/DB21287
    Experimental

    Metacetamol is a small molecule drug. Metacetamol has a monoisotopic molecular weight of 151.06 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors
  10. Drug

    Fluroxene

    go.drugbank.com/drugs/DB20681
    Experimental

    Fluroxene is a small molecule drug. Fluroxene has a monoisotopic molecular weight of 126.03 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates